Stocks analysis

Analysis for DLTR

$124.41 +2.65 (+2.18%)
  • 📈 Growth — 16/30
  • 💰 Profitability — 12/20
  • 🏦 Financial Health — 14/20
  • 💵 Valuation — 10/20
  • ⚠️ Risk — 7/10
Overall Score: 55/100

Summary:


📈 Growth & Financial Trajectory

Eight quarters show a resilient topline: revenues rose from about $4.06B in 2024 Q2 to about $4.89B in 2026 Q2, with a peak near $5.00B in late 2025. Net income swung from a large quarterly loss (roughly $(3.70)B in 2024 Q4) to a positive $514.5M in the latest quarter. Operating momentum improved as operating income reached $690.1M; gross profit was around $2.10B on $4.89B revenues. Cash generated from operations has strengthened, with the latest quarter showing $921.5M, and total net cash flow close to breakeven at about $51M.

💰 Margins & Cash Flow

Gross margin varied, hovering around mid-40s in stronger quarters and mid-30s in softer periods, yielding gross profit of roughly $1.83B–$2.10B across the window. SG&A kept pace with sales, supporting positive earnings in recent quarters, with Basic EPS $2.70. Cash flow from operating activities has been positive in the recent eight quarters, culminating in $921.5M in the latest period, while investing and financing outflows remained meaningful but trending down.

🛡️ Balance Sheet & Liquidity

Assets near $14.0B and equity around $3.43B; liabilities around $10.6B provide a reasonable balance sheet. Current assets exceed current liabilities by a healthy margin, supporting liquidity around 1.1–1.2x. Noncurrent liabilities are sizable but offset by stable equity.

⚠️ Key Drivers & Risks

  • Drivers: Discount retail demand and incremental footprint/e-commerce.
  • Risks: earnings volatility from cost pressures, cyclicality, and sensitivity to margin compression.

📊 Key Financial Fundamentals

Valuation Multiples
Market Cap $21.37B
P/E Ratio 13.25
Forward P/E 17.59
P/S Ratio 1.06
P/B Ratio 7.26
EV / EBITDA 7.98
Profitability & Returns
Gross Margin 38.74%
Operating Margin 11.06%
Net Margin 8.03%
ROE 45.58%
ROIC 25.29%
Financial Health & Liquidity
Current Ratio 1.13
Quick Ratio 0.39
Financial Scale & Cash Flow
Revenue $20.07B
Net Income $1.61B
FCF Yield 9.52%
Free Cash Flow $2.03B
Total Debt To Equity 0.86